Instrument Inactif

Communiqués Endologix, Inc. Nasdaq

Actions

US29266S1069

Equipement, fournitures et distribution médicale

Communiqués

01/10/20	ENDOLOGIX INC /DE/ : Other Events (form 8-K)	AQ
10/08/20	ENDOLOGIX : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
13/07/20	Endologix : Ninth Circuit Addresses High Standard For Pleading Scienter Under Private Securities Litigation Reform Act	AQ
09/07/20	ENDOLOGIX INC /DE/ : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
06/07/20	ENDOLOGIX INC /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/07/20	Endologix : Endologix Enters into an Agreement with Deerfield Partners to Take the Company Private	BU
01/07/20	ENDOLOGIX INC /DE/ : Entry into a Material Definitive Agreement (form 8-K)	AQ
25/06/20	Endologix : Sight Sciences Strengthens Its Leadership Team with Chief Operating Officer and General Counsel Hires	PR
24/06/20	ENDOLOGIX INC /DE/ : Change in Directors or Principal Officers (form 8-K)	AQ
19/06/20	ENDOLOGIX INC /DE/ : Change in Directors or Principal Officers (form 8-K)	AQ
19/06/20	Endologix : Ninth Circuit Affirms Dismissal In Stock-Drop Lawsuit, Citing Shareholder's "Implausible" Scienter Theory	AQ
18/06/20	Endologix : Announces Departure of CFO and Appointment of Interim CFO	BU
15/06/20	Endologix : Issues Correction Notice for Ovation iX Abdominal Stent Graft System	BU
15/06/20	ENDOLOGIX INC /DE/ : Entry into a Material Definitive Agreement (form 8-K)	AQ
11/06/20	ENDOLOGIX INC /DE/ : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
28/05/20	ENDOLOGIX INC /DE/ : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
27/05/20	ENDOLOGIX : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
11/05/20	ENDOLOGIX INC /DE/ : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/05/20	Endologix: 1Q Earnings Snapshot	AQ
11/05/20	Endologix : Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System	BU
11/05/20	Endologix : Reports First Quarter 2020 Financial Results	BU
01/05/20	Endologix, Inc. : to Announce First Quarter 2020 Financial Results on May 11, 2020	BU
27/04/20	ENDOLOGIX INC /DE/ : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
22/04/20	ENDOLOGIX INC /DE/ : Change in Directors or Principal Officers (form 8-K)	AQ
14/04/20	Endologix : Appoints Tim A. Benner as Chief Commercial Officer	BU